Workflow
公司盈利预测
icon
Search documents
Keysight (KEYS) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
ZACKS· 2025-08-14 14:16
Core Insights - Analysts project that Keysight (KEYS) will report quarterly earnings of $1.68 per share, reflecting a 7% year-over-year increase [1] - Revenue is expected to reach $1.31 billion, marking a 7.9% increase from the same quarter last year [1] Earnings Estimates - The consensus EPS estimate has been revised 0.8% lower over the last 30 days, indicating a reevaluation by analysts [2] - Revisions to earnings projections are crucial for predicting investor behavior and short-term stock performance [3] Revenue Projections - Revenue from the Communications Solutions Group is estimated at $917.23 million, an increase of 8.3% year over year [5] - Revenue from Commercial Communications is projected at $617.75 million, reflecting an 8% increase from the prior-year quarter [5] - Revenue from Aerospace, Defense & Government is estimated at $299.47 million, suggesting an 8.9% year-over-year increase [6] - Revenue from the Electronic Industrial Solutions Group is expected to reach $396.45 million, indicating a 7.2% increase year over year [6] Income from Operations - Income from operations for the Electronic Industrial Solutions Group is projected at $88.33 million, up from $74.00 million a year ago [7] - Income from operations for the Communications Solutions Group is expected to be $253.54 million, compared to $223.00 million in the same quarter last year [7] Stock Performance - Over the past month, Keysight shares have returned +6.2%, outperforming the Zacks S&P 500 composite's +3.5% change [8] - Keysight holds a Zacks Rank 3 (Hold), suggesting performance alignment with the overall market in the upcoming period [8]
Stay Ahead of the Game With Eaton (ETN) Q2 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2025-07-31 14:16
Core Insights - Analysts forecast Eaton (ETN) to report quarterly earnings of $2.92 per share, reflecting a year-over-year increase of 7% and revenues of $6.93 billion, which is a 9.1% increase compared to the previous year [1] Earnings Estimates - The consensus EPS estimate has remained unchanged over the past 30 days, indicating that analysts have not revised their projections during this period [2] - Revisions to earnings projections are crucial for predicting investor behavior and are strongly linked to short-term stock price performance [3] Key Metrics Forecast - Estimated 'Net Sales- eMobility' is projected at $191.13 million, showing a year-over-year change of +1.1% [5] - 'Net Sales- Aerospace' is expected to reach $1.03 billion, indicating a +7.9% change from the prior year [5] - 'Net Sales- Vehicle' is forecasted at $674.75 million, reflecting a -6.7% change from the previous year [5] - 'Net Sales- Electrical Global' is anticipated to be $1.70 billion, with a +5.9% year-over-year change [6] - 'Net Sales- Electrical Americas' is projected to reach $3.31 billion, indicating a +15.2% change [6] Segment Operating Profit Estimates - 'Segment operating profit (loss)- Aerospace' is expected to be $239.31 million, up from $206.00 million in the same quarter last year [6] - 'Segment operating profit (loss)- Vehicle' is forecasted at $108.81 million, down from $130.00 million in the same quarter last year [7] - 'Segment operating profit (loss)- Electrical Global' is projected to be $327.71 million, compared to $305.00 million in the same quarter last year [7] - 'Segment operating profit (loss)- Electrical Americas' is expected to reach $975.36 million, up from $859.00 million in the previous year [8] Stock Performance - Over the past month, Eaton shares have returned +8.9%, outperforming the Zacks S&P 500 composite's +2.7% change [8] - Currently, ETN holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [8]
Biogen (BIIB) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
ZACKS· 2025-07-30 14:15
Core Viewpoint - Analysts forecast a significant decline in Biogen Inc.'s quarterly earnings and revenues, indicating potential challenges for the company in the upcoming earnings release [1][2]. Financial Performance Estimates - Expected earnings per share (EPS) for Biogen is $3.94, reflecting a year-over-year decline of 25.4% [1]. - Anticipated revenues are projected at $2.32 billion, which is a decrease of 5.8% compared to the same quarter last year [1]. Revisions and Trends - Over the past 30 days, the consensus EPS estimate has been revised downward by 2.7%, indicating a shift in analysts' expectations [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock performance [3]. Product Revenue Estimates - Revenue from the product TYSABRI for Multiple Sclerosis is estimated at $372.66 million, down 19.4% year-over-year [5]. - Revenue from SPINRAZA for Rare Disease is projected at $396.92 million, indicating a decline of 7.5% year-over-year [5]. - SKYCLARYS for Rare Disease is expected to generate $128.37 million, showing a year-over-year increase of 28.4% [5]. Detailed Product Revenue Breakdown - Total net product revenue is estimated to be $1.72 billion, reflecting a year-over-year decrease of 9.5% [6]. - TYSABRI revenue in the United States is projected at $203.91 million, down 18% year-over-year [6]. - Revenue from TECFIDERA in the United States is expected to be $32.02 million, indicating a decline of 27.4% year-over-year [7]. Additional Revenue Insights - SPINRAZA revenue from the Rest of World is estimated at $244.01 million, down 10.2% from the previous year [8]. - Revenue from SPINRAZA in the United States is projected at $156.29 million, showing a slight decline of 0.6% year-over-year [8]. - Revenue from Interferon products in the United States is expected to be $129.57 million, reflecting a decrease of 10.9% year-over-year [9]. Stock Performance - Over the past month, Biogen's shares have decreased by 1.7%, contrasting with a 3.4% increase in the Zacks S&P 500 composite [10]. - Biogen currently holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [10].
Seeking Clues to Snap-On (SNA) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
ZACKS· 2025-07-14 14:16
Core Viewpoint - Analysts project Snap-On (SNA) will report quarterly earnings of $4.61 per share, a decline of 6.1% year over year, with revenues expected to reach $1.15 billion, down 2.2% from the same quarter last year [1] Earnings Estimates - There has been no revision in the consensus EPS estimate for the quarter over the last 30 days, indicating analysts' collective reconsideration of their initial forecasts [1][2] - Changes in earnings estimates are crucial for predicting investor reactions to the stock [2] Key Metrics Projections - Analysts estimate 'Net Sales- Repair Systems & Information Group' will reach $469.57 million, reflecting a year-over-year increase of 3.3% [4] - 'Net Sales- Snap-on Tools Group' is expected to be $467.58 million, indicating a decline of 3% year over year [4] - 'Net Sales- Commercial & Industrial Group' is projected at $359.03 million, down 3.5% year over year [4] Operating Earnings Forecast - 'Operating earnings / (losses)- Financial services' is expected to be $68.73 million, compared to $70.20 million from the previous year [5] - 'Operating earnings / (losses)- Commercial & Industrial Group' is forecasted at $57.86 million, down from $62.20 million year over year [5] - 'Operating earnings / (losses)- Snap-on Tools Group' is projected at $107.02 million, compared to $114.80 million in the same quarter last year [6] - 'Operating earnings / (losses)- Repair Systems & Information Group' is expected to be $112.74 million, slightly down from $113.60 million year over year [6] Stock Performance - Over the past month, Snap-On shares have returned +2.4%, while the Zacks S&P 500 composite has changed +4% [7] - Snap-On currently holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [7]
Stay Ahead of the Game With Hilton Worldwide (HLT) Q1 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2025-04-25 14:20
Core Insights - Analysts project Hilton Worldwide Holdings Inc. (HLT) will report quarterly earnings of $1.61 per share, reflecting a year-over-year increase of 5.2% [1] - Revenue is expected to reach $2.71 billion, also representing a 5.2% increase from the same quarter last year [1] Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been adjusted upward by 0.1%, indicating a reassessment by covering analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock performance [3] Revenue Breakdown - Analysts estimate 'Revenues- Other revenues from managed and franchised properties' at $1.61 billion, a 5.8% increase year-over-year [5] - 'Revenues- Owned and leased hotels' are projected at $258.21 million, indicating a 1.3% increase from the prior year [5] - 'Revenues- Other revenues' are expected to reach $55.03 million, reflecting a 10.1% increase year-over-year [6] - 'Revenues- Franchise and licensing fees' are forecasted at $629.00 million, suggesting a 10.2% increase [6] - 'Revenues- Incentive management fees' are estimated at $67.81 million, showing a year-over-year decrease of 3.1% [7] - 'Revenues- Base and other management fees' are projected at $88.41 million, indicating a significant decline of 16.6% from the previous year [7] Property Metrics - Total Owned / Leased Rooms are projected to be 17,109, down from 17,492 in the same quarter last year [8] - Revenue per available room - System-Wide is expected to reach $106.21, compared to $104.16 a year ago [8] - Total Systemwide Rooms are forecasted to be 1,273,692, up from 1,197,329 in the previous year [8] Stock Performance - Over the past month, shares of Hilton Worldwide have returned -5.5%, compared to a -4.8% change in the Zacks S&P 500 composite [9] - Currently, HLT holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [9]